Alpha Teknova, Inc. (TKNO) News
Filter TKNO News Items
TKNO News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
TKNO News Highlights
- For TKNO, its 30 day story count is now at 2.
- Over the past 16 days, the trend for TKNO's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
Latest TKNO News From Around the Web
Below are the latest news stories about ALPHA TEKNOVA INC that investors may wish to consider to help them evaluate TKNO as an investment opportunity.
Alpha Teknova Insiders Land Bargain With Gains Of US$1.4mInsiders who bought Alpha Teknova, Inc. ( NASDAQ:TKNO ) stock lover the last 12 months are probably not as affected by... |
Alpha Teknova (TKNO) Posted Better Than Expected Results in Q3Conestoga Capital Advisors, an asset management company, released its “Micro Cap Strategy” third-quarter 2023 investor letter. A copy of the same can be downloaded here. The micro capitalization segment of the market proved the most challenging in the quarter with the Russell Micro Cap Index declining -7.93%. The Russell Micro Cap Growth Index fell further with a […] |
Alpha Teknova, Inc. (NASDAQ:TKNO) Q3 2023 Earnings Call TranscriptAlpha Teknova, Inc. (NASDAQ:TKNO) Q3 2023 Earnings Call Transcript November 11, 2023 Operator: Hello, and welcome to Alpha Tech Nova, Inc. Third Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions] I would now like to […] |
Teknova Reports Third Quarter 2023 Financial ResultsRaised $22.9 million of equity capital, paid down $10.0 million of long-term debtThird quarter 2023 total revenue was $8.2 million, down 24% from prior yearExpect 2023 revenue at the low end of previously announced guidance range of $37-40 million HOLLISTER, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova” or the “Company”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecu |
Teknova to Report Third Quarter 2023 Financial Results on November 9, 2023HOLLISTER, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the third quarter ended September 30, 2023, on Thursday, November 9, 2023, following the close of market. Teknova will host a webcast and conference call on Thursday, November 9 |
Teknova Launches Latest Proprietary AAV-Tek™ Product and End-to-End Plasmid Workflow Solutions to Streamline Therapeutic Process DevelopmentNovel AEX screening kit – now available for AAV6 – and an expansive suite of high-quality reagents designed to expedite plasmid production will help accelerate breakthroughs across multiple AAV constructs and workflowsHOLLISTER, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today launched the |
Insiders Pour Millions Into These 2 Beaten-Down Stocks, Analysts Say They Could Be Ready to Bounce Back — Here’s Why You Should Take NoticeIn the world of stock markets, a well-known adage prevails: insiders may sell shares of their own companies for a myriad of reasons, but their decision to buy stock typically hinges on one belief – that the shares are set to rise. By insiders, we mean the corporate officers that sit on company boards and are the in-the-know types with access to the sort of information not available to the casual investor. By law, they are required to make their purchases public, thereby keeping the playing field |
Teknova Announces Closing of $22.9 Million Concurrent Registered Direct Offering and Private Placement and Amends Credit FacilityHOLLISTER, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced the closing of its previously announced registered direct offering for the issuance and sale of an aggregate of 1,086,485 of its shares of common stock at a purchase price of $1.85 per share and concurrent private placement of an ag |
Teknova Announces Up to $22.9 Million Concurrent Registered Direct Offering and Private PlacementHOLLISTER, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that it has entered into definitive agreements for the issuance and sale of an aggregate of up to 1,086,485 of its shares of common stock in a registered direct offering at a purchase price of $1.85 per share. In a concurrent privat |
Teknova Announces New Board Member, Martha J. DemskiHOLLISTER, Calif., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced the appointment of Martha J. Demski to its Board of Directors, bringing to the Board more than 35 years of experience in corporate leadership and life sciences business and financial strategies. She will replace Robert McNamara, who |